The Center for Biosimilars Council has noted that 90% of biologics losing patent protection over the next decade currently have no biosimilar in development a fact that restructures LOE revenue models for many assets in the 20282035 window
#PharmaLeadership #BiotechStrategy #BoardGovernance #IL23 #PsoriasisTreatment #StrategicCannibalization #LifecycleManagement #CommercialStrategy #DrugDevelopment #HealthcareInnovation #Leadership #Strategy To view or add a comment, sign in Good leaders do not try to prove theyre smart
I.GaleanoP.HolubiecM.BadorreyM
Shao N, Yu XY, Ma XF, Lin WJ, Hao M, Kuang HY
Shah UK, Chaudhary S, Ghimire A, et al
Down 30 inches! Michael, 40 Month 1 Month 4 Pregnancy weight felt impossible to lose